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Cyclic nigerosylnigerose (CNN) is a cyclic oligosaccharide. Oral administration of CNN promotes immunoglobulin 
A (IgA) secretion in the gut. IgA is a major antibody secreted into the gut and plays a crucial role in suppressing 
gut inflammation due to commensal gut microbiota. To investigate the effect of administration of CNN to promote 
IgA secretion on gut inflammation, experimental colitis was induced with dextran sulfate sodium (DSS) in Balb/c 
mice after 6 weeks of CNN pre-feeding. The severity of colitis was evaluated based on a disease activity index 
(DAI), the gene expression of inflammatory cytokines, and a histological examination. The CNN-treated mice with 
DSS-induced colitis (CNN-DSS group) showed significantly lower DAI scores and mRNA levels of interleukin-1 
compared with the CNN-untreated mice with DSS-induced colitis (DSS group). Histological examination of the 
colon revealed that the pathological score was significantly lower in the CNN-DSS group compared with the DSS 
group due to the reduced infiltration of immune cells. The number of goblet cells was significantly higher in the 
CNN-DSS group compared with the DSS group. The IgA concentration and the ratio of microbiota coated with 
IgA were evaluated in the cecal content. Although there was no difference in the IgA concentration among groups, 
a higher proportion of cecal microbiota were coated with IgA in the CNN-DSS group compared with that in the 
DSS group. These results suggest that CNN might preserve goblet cells in the colon and promote IgA coating of 
gut microbiota, which synergistically ameliorate gut inflammation in mice with DSS-induced colitis.
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INTRODUCTION
Inflammatory bowel diseases (IBDs) comprise a group of 
heterogeneous chronic and relapsing inflammatory gut disorders 
that include ulcerative colitis and Crohn’s disease. Previous 
studies have suggested that IBDs are associated with an 
abnormal composition of gut microbiota. Compared with healthy 
individuals, several opportunistic pathogens and a smaller number 
of beneficial microbiota are found in the gut of IBD patients [1–3]. 
Moreover, depletion of gut microbiota by antibiotic treatment 
ameliorates clinical symptoms in IBD patients [2], suggesting 
that excessive inflammatory responses against gut microbiota are 
a major factor affecting the onset of gut inflammation. The use 
of dietary ingredients that can modulate the composition of gut 
microbiota and, therefore, suppress gut inflammation has recently 
become a focus of interest for the prevention of IBDs [4].
Cyclic nigerosylnigerose (CNN) is a cyclic oligosaccharide 
composed of four D-glucopyranosyl residues linked by alternating 
α-1,3 and β-1,6 glucosidic linkages. CNN is found naturally in 
Japanese sake (2.2 µg/mL) and sake lees (206 µg/g) [5] and 
can also be synthesized from maltodextrins by a combined 
reaction of two transferases [6, 7]. A previous study showed that 
oral administration of CNN increased the immunoglobulin A 
(IgA) concentration in mouse feces [8]. IgA, a major antibody 
isotype expressed in the gut, helps to maintain gut homeostasis 
[9–11]. One of the major functions of IgA is immune exclusion of 
pathogenic microbes by restricting access to the epithelial surface 
[10, 12]. Furthermore, recent studies have shown that IgA plays 
a crucial role in suppressing gut inflammation due to commensal 
microbiota. Kubinak et al. showed that decreased IgA coating 
of gut microbiota in mice that are deficient in T cell MyD88 
expression resulted in more severe gut inflammation following 
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2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis 
compared with that in wild-type mice [13]. Furthermore, Peterson 
et al. showed that IgA, which is specific for gut bacterial antigens, 
suppressed proinflammatory gut signaling [14]. Although we 
observed that oral administration of CNN enhanced IgA secretion 
in the gut, the role of the IgA secreted after CNN ingestion remains 
unclear. Since the IgA coating of gut microbiota helps regulate gut 
inflammation, we hypothesized that the stimulatory effect of CNN 
on IgA secretion in the gut might be useful for suppressing gut 
inflammation. To validate our hypothesis, we evaluated the effect 
of oral administration of CNN on symptoms of dextran sulfate 
sodium (DSS)-induced colitis in mice. Moreover, the ratio of IgA-
coated microbiota in the cecal content was evaluated to understand 
whether CNN-treated IgA coats gut microbiota.
MATERIALS AND METHODS
This study was approved by the Animal Care and Use Committee 
of Okayama University, Japan (approval no. OKU-2016399), and 
complies with the institutional and national guidelines for the care 
and use of laboratory animals.
Animals and treatment
Ten-week-old female Balb/c mice were obtained from Charles 
River Laboratories Japan (Yokohama, Japan). Mice were given 
a commercial pelleted diet (Labo MF stock, Nosan Corporation, 
Kanagawa, Japan) and were allowed free access to water. After 
a 7-day adaptation period, mice were divided into three groups: 
control group, DSS-induced colitis group (DSS group), and DSS-
induced colitis with CNN treatment group (CNN-DSS group) (n=5 
for each group). All groups were fed Labo MF stock ad libitum. 
CNN (Hayashibara Co., Ltd., Okayama, Japan) was added to water 
at a concentration of 22.5 mg/mL and given to CNN-DSS mice as 
their drinking water. The concentration of CNN used to promote 
gut IgA secretion was determined with reference to a previous 
study [8]. The mice were kept at room temperature (25°C) under 
a controlled 12 hr light/dark cycle. Induction of IgA secretion 
with CNN was performed as previously described [8]. Briefly, a 
six-week feeding period was set, after which feces were collected 
for measurement of the IgA concentration. After confirming that 
CNN significantly increased fecal IgA concentrations, colitis was 
induced by treatment with 1.5% (w/v) DSS (MW = 1,000-9,000, 
dissolved in drinking water; Wako Pure Chemical, Tokyo, Japan) 
in the DSS and CNN-DSS groups. The severity of DSS-induced 
colitis was assessed twice a week using a disease activity index 
(DAI) based on the scoring system shown in Table 1 [15], 
which scores based on loss of body weight, stool consistency, 
and rectal bleeding. DAI scores were assessed until 14 days 
post-DSS treatment. On day 14 post-DSS treatment, mice were 
anesthetized by intraperitoneal administration of pentobarbital 
(30 mg/kg) and euthanized by cervical dislocation. The colon was 
collected and its length was measured. The distal colon was cut 
into three segments for gene expression analysis, measurement of 
myeloperoxidase (MPO) activity, and histological examination. 
The cecal content was collected to evaluate microbial composition, 
IgA concentration, and IgA reactivity against gut microbiota. 
Independent animal experimentation was performed in duplicate.
Gene expression of inflammatory cytokines in the colon
The mRNA levels of inflammatory cytokines, interleukin-1β 
(il1b), interleukin-6 (il6), and monocyte chemoattractant protein-1 
(mcp1), were evaluated by quantitative real-time PCR. Total RNA 
was extracted from the distal colon using ISOGEN II, according 
to the manufacturer’s protocol (Nippon Gene, Tokyo, Japan). 
Complementary DNA (cDNA) was synthesized from 500 ng 
total RNA using ReverTra Ace with random primers (Toyobo, 
Osaka, Japan). The synthesized cDNA was mixed with primer 
pairs and GeneAce SYBR qPCR Mix α (Nippon Gene, Tokyo, 
Japan). Amplifications were performed in an AriaMx Real-
Time PCR System (Agilent Technologies Japan, Tokyo, Japan) 
using the following temperature profiles: one cycle at 95°C for 
10 min, followed by 40 cycles of denaturation at 95°C for 30 sec 
and annealing at 60°C for 60 sec. Sample quantification cycle 
(Cq) values were normalized against that of the housekeeping 
gene, glyceraldehyde 3-phosphate dehydrogenase (gapdh). 
Fold changes compared with the control group were then 
calculated using the 2-∆∆Cq method. The primer pairs used 
were as follows: 5′-TCAAGAAGGTGGTGAAGCAG-3′ 
a n d  5 ′ - A G T G G G A G T T G C T G T T G A A G T- 3 ′  f o r 
gapdh ,  5 ′ -CAACCAACAAGTGATATTCTCCATG-3′ 
a n d  5 ′ - G AT C C A C A C T C T C C A G C T G C A - 3 ′  f o r 
i l 1 b ,  5 ′ - G A G G ATA C C A C T C C C A A C A G A C C - 3 ′ 
and 5 ′‐AAGTGCATCATCGTTGTTCATACA-3′  for 
il6, and 5′-CTTCTGGGCCTGCTGTTCA-3′ and 5′‐
CCAGCCTACTCATTGGGATCA-3′ for mcp1.
MPO activity
The MPO activity in the colon was assessed using a protocol 
described by Kim et al. [16]. In brief, frozen colonic tissue was 
homogenized in 50 mM potassium phosphate buffer containing 
13.7 mM hexadecyltrimethylammonium bromide (pH 6.0) with 
zirconia beads (2.3 mm diameter) using Beads Crusher μT-12 
(1,800 rpm, 2 × 30 sec, Taitec, Tokyo, Japan) and centrifuged 
at 4°C at 12,000 × g for 15 min. Seven microliters of the 
supernatant was mixed with 200 µL of 0.167% (w/v) o-dianisidine 
dihydrochloride (Sigma-Aldrich Japan, Tokyo, Japan) and 
0.0006% (v/v) hydrogen peroxide (Sigma-Aldrich Japan, Tokyo, 
Japan) solution. The protein concentration was measured using a 
commercial bicinchoninic acid kit according to the manufacturer’s 
instructions (Nacalai Tesque, Kyoto, Japan). MPO activity was 
expressed as the change in absorbance at 450 nm/min/mg protein.
Histological examination of colonic tissue
The distal colon was cut and fixed with 10% neutral phosphate-
buffered formalin (Wako Pure Chemical). The fixed colonic 
tissue was dehydrated, embedded in paraffin, and sectioned into 
Table 1. Criteria for scoring disease activity index (DAI)*
Score Weight loss (%) Stool consistency**   Rectal bleeding
0 None Normal Negative
1 1–5 Loose stool Hemoccult positive
2 5–10 Diarrhea Gross bleeding
3 10–15
4 >15
*DAI was calculated by summing the scores of weight loss, stool 
consistency, and rectal bleeding.
**Normal stools: well formed pellets; loose stool: pasty stool that does not 
stick to the anus; diarrhea: liquid stools that sticks to the anus.
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5-μm-thick slices. For histological analysis, slices were stained 
with standard hematoxylin-eosin (H&E) to evaluate mucosal 
inflammation. For mucus analysis, slices were stained with Alcian 
Blue (pH 2.5) to evaluate them for the presence of goblet cells. 
The cross sections of colonic tissue specimens were examined at 
200× magnification and imaged using an All-in-One Fluorescence 
Microscope (BZ-X710; Keyence, Osaka, Japan). Histological 
score was evaluated for eight microscopic fields of each sample 
using a semiquantitative scoring method, as shown in Table 
2 [17]. The goblet cell number per crypt was counted for eight 
microscopic fields of each sample.
Pyrosequencing of bacterial 16S rRNA gene (V4) amplicon 
sequencing in the cecal content
DNA was extracted from cecal content using a QIAamp stool mini 
kit (Qiagen Japan, Tokyo, Japan), according to the manufacturer’s 
instructions, with additional freeze-thaw and bead-beating steps. 
The extracted DNA was subjected to two-step PCR reactions 
to generate amplicon libraries for next generation sequencing 
(NGS). In the first PCR reaction, primers targeting the V4 region 
of 16S rRNA genes (forward, 5′-ACACTCTTTCCCTACACG 
ACGCTCTTCCGATCTGTGCCAGCMGCCGCGGTAA-3′; 
reverse, 5′-GTGACTGGAGTTCAGACGTGTGCTCTTCCG 
ATCTGGACTACHVGGGTWTCTAAT-3′; tail sequences are 
underlined) were used. Amplification was performed using the 
following temperature profiles: one cycle at 94°C for 2 min, 
followed by 25 cycles of denaturation at 94°C for 30 sec, annealing 
at 50°C for 30 sec, and extension at 72°C for 30 sec, and then 
one cycle at 72°C for 5 min for final extension. The PCR products 
were purified by electrophoretic separation on a 2% (w/v) agarose 
gel using a Fast Gene Gel/PCR Extraction Kit (NIPPON Genetics 
Co., Ltd., Tokyo, Japan) and subjected to a second round of PCR 
with adapter-attached primers. Amplification was performed 
using the following temperature profiles: one cycle at 94°C for 
2 min, followed by 10 cycles of denaturation at 94°C for 30 sec, 
annealing at 59°C for 30 sec, and extension at 72°C for 30 sec, and 
then one cycle at 72°C for 5 min for final extension. PCR products 
were purified as described above for the first-round products. 
The purified amplicons were pair-end sequenced (2 × 250) on 
an Illumina MiSeq platform at FASMAC Co., Ltd. (Kanagawa, 
Japan).
Bioinformatics
The raw paired-end FASTQ reads were demultiplexed using 
idemp (https://github.com/yhwu/idemp/blob/master/idemp.
cp) and imported into the Quantitative Insights Into Microbial 
Ecology 2 program (QIIME2, ver. 2017.9.0, https://qiime2.org/) 
[18]. The Divisive Amplicon Denoising Algorithm 2 (DADA2) 
[19] was used to quality filter, trim, de-noise, and merge the data. 
Chimeric sequences were removed using the consensus method. 
Taxonomic classification was assigned using the SILVA database 
(ver. 132), which was specifically for the V4 region of the 16S 
rRNA gene. All taxonomic classifications were implemented 
within QIIME2 and assigned using the naïve Bayesian algorithm. 
For phylogenetic diversity analysis, sequences were aligned 
using the MAFFT program plugin [20] and used to construct a 
phylogenetic tree with FastTree 2 [21]. Alpha diversity (Chao 
richness, Shannon diversity, and Pielou evenness) was estimated 
using q2-diversity.
Quantification of fecal and cecal IgA concentrations
The feces collected after the 6-week pre-feeding period 
and the cecal content were resuspended in phosphate-buffered 
saline (PBS) and homogenized using a vortex mixer. The IgA 
concentration was measured in the fecal and cecal supernatants 
using a Mouse IgA enzyme-linked immunosorbent assay (ELISA) 
quantification kit (Bethyl Laboratories, Montgomery, TX, USA), 
according to the manufacturer’s instructions. The absorbance of 
each well was read at 450 nm using a microplate reader (Bio-Rad 
Japan, Tokyo, Japan).
Evaluation of ratio of IgA-coated microbiota in the cecal 
content
The ratio of IgA-coated microbiota to total microbiota (IgA 
coating ratio) in the cecal content was measured as previously 
described [22]. Briefly, 100 µg of cecal content was dissolved 
in 900 µL PBS, and the cecal suspension was centrifuged at 100 
× g for 20 min to remove debris. The supernatant was further 
centrifuged at 9,000 × g for 10 min. After centrifugation, the 
resultant bacterial pellet was washed twice with PBS. The bacterial 
cells were then fixed with 4% paraformaldehyde (Wako Pure 
Chemical) overnight at 4°C. After washing twice with PBS, the 
bacterial cells were stained with FITC-labelled anti-mouse IgA 
(BD Pharmingen Japan, Tokyo, Japan) for 30 min. After washing 
twice with PBS, the bacterial cells were stained with propidium 
iodide (PI; Sigma Aldrich Japan) solution (4 µg/mL). The bacterial 
suspension was loaded onto a Gallios flow cytometer (Beckman 
Coulter). Total microbiota and IgA-coated microbiota were 
detected as PI-positive populations and FITC/PI-double positive 
populations, respectively. FCS Express V3 (De Novo Software, 
Los Angeles, CA, USA) was used to calculate the IgA coating ratio.
Statistical analysis
Data were expressed as the mean ± standard error of the mean 
(SEM). All statistical analyses were performed in GraphPad Prism 
version 7.00 for Windows (GraphPad Software, San Diego, CA, 
USA). Bartlett’s test was used to assess homogeneity of variances 
across groups. For datasets with equal variances, group data 
were analyzed using one-way ANOVA with a post-hoc Tukey’s 
test. For nonparametric data, Kruskal-Wallis analysis was used 
Table 2. Criteria for histological scoring
Score
0 No evidence of inflammation.
1 Low level of inflammation with scattered infiltrating mononuclear cells and neutrophils.
2 Moderate inflammation with multiple foci of neutrophils.
3 High degree of inflammation with increased vascular density and marked wall thickening.
4 Maximal severity of inflammation with transmural leukocyte infiltration and loss of goblet cells accompanied by ulceration.
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with Dunn’s multiple comparison test. P<0.05 was considered 
statistically significant.
RESULTS
Body weight change, disease activity index, and colon length
Chemically induced colitis was observed 7 days post-DSS 
administration and was characterized by significant loss of body 
weight, decreased stool consistency, and increased rectal bleeding 
(Fig. 1A and 1B). Body weight was significantly lower in the DSS 
and CNN-DSS groups than in the control group at days 10 and 14; 
however, there were no significant differences in the body weights 
between the DSS and CNN-DSS groups (Fig. 1A). On days 7 and 
14, the DAI score was significantly lower in the CNN-DSS group 
compared with that in the DSS group (Fig. 1B). The colon length 
was significantly reduced after DSS treatment, but there were no 
significant differences between the DSS and CNN-DSS groups 
(Fig. 1C).
Gene expression of inflammatory cytokines in the colon
The mRNA expression levels of the inflammatory cytokine 
genes il1b, il6, and mcp1 in the colon are shown in Fig. 2A. Il1b 
and il6 expression levels were significantly higher in the DSS 
group compared with those in the control group. Il1b expression 
was significantly reduced in the CNN-DSS group compared with 
that in the DSS group. No significant differences were observed 
in Il6 expression between the DSS and CNN-DSS groups. The 
expression of mcp1 tended to be lower in the CNN-DSS group 
compared with that in the DSS group (p=0.0823).
MPO activity in the colon
MPO activity in the colon is shown in Fig. 2B. MPO activity 
significantly increased in the DSS group compared with that in the 
control group. MPO activity tended to be lower in the CNN-DSS 
group compared with that in the DSS group (p=0.1703).
Histological examination of colonic tissue
The distal colon of the DSS group presented with marked crypt 
destruction, infiltration of multiple inflammatory cells, and loss 
of goblet cells. Although the histological score was significantly 
higher in the DSS and CNN-DSS groups compared with that in the 
control group, the CNN-DSS group showed a significantly lower 
histological score compared with the DSS group due to the reduced 
infiltration of immune cells and loss of goblet cells (Fig. 3A and 
3B). Alcian Blue staining revealed that the goblet cell number 
per crypt was significantly decreased in the DSS and CNN-DSS 
groups compared with that in the control group. Interestingly, 
however, the decrease induced by DSS was ameliorated by CNN 
treatment (Fig. 3C and 3D).
Phylogenetic diversity of cecal microbiota
The composition of microbial communities was analyzed by 
calculating three major ecological parameters: Chao richness (an 
estimate of a total community), Pielou evenness (a measure of how 
evenly the individuals within a community are distributed over 
different operational taxonomic units), and Shannon diversity (the 
combined parameter for richness and evenness). Although these 
ecological parameters decreased in the DSS group compared with 
those in the control group, there were no significant differences 
among the experimental groups (Fig. 4).
Relative abundance of cecal microbiota
The microbial composition at the phylum level is shown in Fig. 
5A. The relative abundance of Bacteroidetes tended to be higher 
in the DSS group (44.46 ± 5.62%) compared with that in the 
control (34.11 ± 3.48%) and CNN-DSS groups (35.21 ± 5.82%). 
The relative abundance of Firmicutes tended to be lower in the 
DSS group (49.07 ± 4.94%) compared with that in the control 
(58.48 ± 2.74%) and CNN-DSS groups (57.75 ± 4.48%) (Fig. 
5A), although there were no significant differences in any of the 
phyla among the experimental groups. The microbial composition 
at the family level is shown in Fig. 5B. There were no significant 
differences in the relative abundances of any families among the 
experimental groups. The relative abundances of microbial taxa 
that were significantly different among experimental groups are 
shown in Fig. 5C. The relative abundance of the Lachnospiraceae 
NK4A136 group was significantly higher in the CNN-DSS group 
Fig. 1. Effects of cyclic nigerosylnigerose (CNN) on body weight, 
disease activity index, and colon length in mice with DSS-induced 
colitis. (A) Body weight. (B) Disease activity index. (C) Colon 
length. Con: control group; DSS: DSS group; CNN-DSS: CNN-DSS 
group. Data are expressed as the mean ± SEM. Values without a 
common letter are statistically significantly different (p<0.05).
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compared with that in the DSS group, but not that in the control 
group. The relative abundance of Muribaculaceae unclassified 
genus A was significantly higher in the control group compared 
with that in the DSS and CNN-DSS groups. The relative abundance 
of Muribaculaceae unclassified genus B was significantly higher 
in the DSS and CNN-DSS groups compared with that in the 
control group.
Fecal and cecal IgA concentrations
The IgA concentrations in the feces collected after 6 weeks of 
CNN pre-feeding and cecal content on day 14 post-DSS treatment 
are shown in Fig. 6A and 6B, respectively. CNN pre-feeding 
for 6 weeks significantly increased the fecal IgA concentration 
compared with the control group (Fig. 6A). After DSS treatment, 
there were no significant differences in the cecal IgA concentration 
among the experimental groups (Fig. 6B).
IgA coating ratio in the cecal content
Representative results of flow cytometry for the detection 
of IgA-coated bacteria in the cecal content are shown in Fig. 
6C. A quadrant gate was drawn using the single‐color controls 
to determine FITC- and PI-positive populations. IgA-coated 
bacteria are located within the upper right quadrant in the dot 
plot as a FITC- and PI-positive population. The IgA coating ratio 
in the cecal content tended to be higher in the CNN-DSS group 
compared with those in the control group (p=0.0566) and DSS 
group (p=0.0705) (Fig. 6D), although there was no difference 
between the control and DSS groups.
DISCUSSION
DSS-induced colitis is a gut inflammation model that resembles 
human ulcerative colitis [23]. Although the etiology of IBDs is 
not fully understood, some reports have suggested that an aberrant 
immune response against gut microbiota might be a major cause of 
gut inflammation [24]. Therefore, factors that suppress excessive 
inflammatory responses against commensal microbiota in the gut 
have been thought to prevent the development of IBDs. CNN is a 
cyclic oligosaccharide that can promote IgA secretion in the gut. 
Previous studies have suggested that by coating gut microbiota, 
IgA may be important for establishing a symbiotic relationship 
with gut microbiota without inducing gut inflammation [13, 14]. In 
the current study, we examined the effect of oral administration of 
CNN on severity of colitis, inflammatory state in the colon, colonic 
histology, goblet cell number, cecal microbiota composition, IgA 
concentration, and IgA coating ratio in DSS-induced colitis mice.
The DAI score was significantly decreased in the CNN-DSS 
group compared with the DSS group. Consistent with the DAI 
score, the DSS-induced increase in il1b expression in the colon 
was significantly reduced by CNN treatment. IL-1β is mainly 
produced by activated macrophages and plays a vital role in the 
incidence of IBD [25]. Our results suggest that CNN treatment 
might alleviate DSS-induced gut inflammation by inhibiting the 
activation of macrophages in the colon. Despite amelioration 
of the DAI score and colonic il1b gene expression in the CNN-
DSS group, the reduction of colon length induced by DSS was 
not recovered by CNN treatment. The cause of this discrepancy 
remains unclear.
MPO is a member of the heme peroxidase superfamily and 
is mainly found in neutrophils. Therefore, colonic MPO activity 
is a measure of neutrophil infiltration into inflamed tissue and is 
considered to be a marker of tissue damage [26]. The increased 
MPO activity induced by DSS was ameliorated by CNN treatment, 
indicating that infiltration of neutrophils into the colonic mucosa 
might be suppressed by CNN treatment. This speculation is 
supported by the significantly lower histological score in the 
CNN-DSS group compared with that in the DSS group due to 
decreased infiltration of immune cells.
Mucus is continuously secreted by colonic goblet cells and 
is mainly composed of heavily O-glycosylated proteins called 
mucins [27, 28]. Mucus layers play an important role in separating 
gut microbiota and colonic epithelial cells [29]. In this study, 
Fig. 2. Effects of cyclic nigerosylnigerose (CNN) on gene expression 
levels of inflammatory cytokines (A) and MPO activity (B) in the 
colon of mice with DSS-induced colitis. Con: control group; DSS: 
DSS group; CNN-DSS: CNN-DSS group. The gene expression levels 
of il1b, il6, and mcp1 are shown as mRNA levels relative to that in the 
control group. Data are expressed as the mean ± SEM. Values without 
a common letter are statistically significantly different (p<0.05).
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DSS-induced loss of goblet cells was partly restored by CNN 
treatment. Similar results were observed for other food ingredients 
and probiotic bacteria. Wang et al. showed that dietary grape seed 
extract improved gut inflammation with an increase in the colonic 
goblet cell number in IL10-deficient mice, which spontaneously 
developed colitis [30]. Moreover, oral administration of 
Bifidobacterium longum CCM7952 suppressed the loss of goblet 
cells and ameliorated the symptoms of DSS-induced colitis in 
mice [31]. Our observations suggested that since CNN is able to 
preserve goblet cells in the colon, it may play a crucial role in the 
prevention of gut inflammation.
Previous studies have shown that the number of goblet cells 
in the colon is affected by gut microbiota. Wrzosek et al. showed 
that goblet cell differentiation was promoted in Bacteroides 
thetaiotaomicron mono-associated mice but was suppressed 
by Faecalibacterium prausnitzii [32]. Furthermore, oral 
administration of grape seed extract has been shown to increase 
the number of goblet cells in IL-10-deficient colitis mice while 
increasing the relative abundance of the genus Bacteroides and 
decreasing that of F. prausnitzii [30]. In this study, we compared 
the relative abundances of B. thetaiotaomicron and F. prausnitzii 
in the cecal content among the groups by quantitative PCR using 
specific primer pairs. There were no significant differences in 
the relative abundances of B. thetaiotaomicron and F. prausnitzii 
among the groups (data not shown). Our results suggest that CNN 
might restore the loss of goblet cells via mechanisms other than 
the modification of gut microbial composition. These mechanisms 
should be the focus of future studies.
Fig. 3. Effects of cyclic nigerosylnigerose (CNN) on the histology and the number of goblet cells in the colonic tissue of mice with DSS-induced 
colitis. (A) Representative images of H&E-stained colonic tissues. (B) Histological score. (C) Representative images of colonic tissues stained with 
Alcian Blue (AB). (D) Number of AB-positive cells. AB-positive cells are indicated by arrows. Con: control group; DSS: DSS group; CNN-DSS: 
CNN-DSS group. Data are expressed as the mean ± SEM. Each section is shown at 200× magnification. The black scale bar indicates 100 μm for 
all panels. Values without a common letter are statistically significantly different (p<0.05).
Fig. 4. Effects of cyclic nigerosylnigerose (CNN) on the phylogenetic diversity of cecal microbiota in mice with DSS-induced colitis. (A) Chao 
richness, (B) Shannon diversity, and (C) Pielou evenness. Data are expressed as the mean ± SEM. Con: control group; DSS: DSS group; CNN-DSS: 
CNN-DSS group.
T. Tsuruta, et al. 194
doi: 10.12938/bmfh.2020-012 ©2020 BMFH Press
Changes in the composition of gut microbiota have been linked 
to the pathogenesis of IBD [33]. Three ecological parameters, 
Chao richness, Pielou evenness, and Shannon diversity, were 
reduced in mice with DSS-induced colitis and in IBD patients [33, 
34]. In this study, although these parameters seemed to be reduced 
by DSS treatment, which was consistent with previous studies, 
DSS-induced changes in these parameters were not restored by 
CNN treatment. These data suggest that CNN treatment might 
not influence the richness, evenness, and diversity of microbial 
communities.
Praengam et al. showed that oral administration of brown rice 
alleviated gut inflammation in mice with DSS-induced colitis and 
reversed DSS-induced changes in gut microbial composition, 
such as decreased Firmicutes and increased Bacteroidetes [4]. 
Similar to this study, CNN treatment tended to change the gut 
microbial composition in DSS-induced colitis mice at the phylum 
level. Our study also revealed that the CNN-DSS group showed 
a significantly higher relative abundance of Lachnospiraceae 
NK4A136 compared with the DSS group despite there being no 
difference in cecal total bacteria among all groups (data not shown). 
Hu et al. suggested that the Lachnospiraceae NK4A136 group 
might play a pivotal role in suppressing chronic inflammation 
in high-fat diet-induced obese mice by producing butyrate [35]. 
Short-chain fatty acids, mainly consisting of acetate, propionate, 
and butyrate, are metabolites of gut microbiota, which can inhibit 
inflammatory responses [36, 37]. Our observation suggests that a 
shift in Lachnospiraceae NK4A136 induced by CNN may partly 
contribute to its anti-inflammatory effect.
The IgA coating ratio in the cecal content tended to be higher 
in the CNN-DSS group compared with those in the control and 
DSS groups. This result suggests that CNN treatment might 
promote IgA coating of gut microbiota. There are three possible 
mechanisms for the increase of the IgA coating ratio induced 
by CNN treatment. The first involves the modification of the 
microbial composition by CNN treatment, which is to say that the 
abundance of certain gut microbiota, preferentially coated with 
IgA, might increase in the CNN-DSS group. The second possible 
mechanism is related to the restoration of the DSS-induced 
loss of goblet cells by CNN treatment. IgA is anchored to the 
outer layer of colonic mucus, possibly via the glycan-dependent 
association of secretory components with mucus proteins [38, 
39]. In the mucus layer, IgA is associated with gut microbiota [38, 
40]. These findings suggest that the IgA-mucus complex might be 
crucial for efficient IgA coating of gut microbiota. The restoration 
of goblet cells induced by CNN treatment might contribute to the 
formation of a complex of IgA, mucus, and microbiota, which 
Fig. 5. Effects of cyclic nigerosylnigerose (CNN) on the composition of cecal microbiota in mice with DSS-induced colitis. Pie chart representation 
of relative abundances of cecal microbiota (A) at the phylum and (B) family levels. (C) Relative abundances of cecal microbiota at the genus 
level that were significantly different among experimental groups. Con: control group; DSS: DSS group; CNN-DSS: CNN-DSS group. Data are 
expressed as the mean ± SEM. Values without a common letter are statistically significantly different (p<0.05).
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might have resulted in the increased IgA coating ratio in the 
CNN-DSS group. The third possible mechanism is an increase in 
IgA reactivity against gut microbiota.
Based on our study, it remains unclear whether the effect of 
CNN on IgA coating of gut microbiota is related to symptoms 
of DSS-induced colitis. Previous studies have revealed that 
specific IgA antibodies against gut microbiota are essential 
to suppress the growth of gut microbiota [14, 41]. Boullier et 
al. reported that monoclonal IgA specific for the pathogenic 
bacterium Shigella flexneri preferentially binds to mucus layers 
and restricts the invasion of S. flexneri into the submucosal area 
[42]. Furthermore, IgA has also been shown to preferentially coat 
inflammation-inducible and invasive gut microbiota to prevent 
gut inflammation [43]. These reports suggest that increased IgA 
coating of gut microbiota induced by CNN may be partly related 
to the effect of CNN in altering gut microbial composition and 
suppressing gut inflammation.
In conclusion, CNN treatment reduced gut inflammation in 
mice with DSS-induced colitis, possibly through synergistic 
effects of restoration of goblet cells, increased abundance of 
butyrate-producing bacteria, and promotion of IgA coating of gut 
microbiota. Furthermore, this study raises the possibility that IgA 
reactivity against gut microbiota may be modulated by dietary 
ingredients. The IgA coating of gut microbiota may be a useful 
marker for identifying beneficial food ingredients that prevent gut 
inflammation.
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Fig. 6. Effects of cyclic nigerosylnigerose (CNN) on the IgA concentration and the IgA reactivity against gut microbiota in the cecal content 
of mice with DSS-induced colitis. IgA concentration (A) in the feces collected after 6 weeks of CNN pre-feeding and (B) cecal content 
on day 14 post-DSS treatment. (C) Representative results of flow cytometry for the detection of IgA-coated bacteria. A quadrant gate was 
drawn to determine FITC- and PI-positive populations. IgA-coated bacteria are located within the upper right quadrant in the dot plot as a 
FITC- and PI-positive population. (D) IgA coating ratio in the cecal content on day 14 post-DSS treatment. Con: control group; DSS: DSS 
group; CNN-DSS: CNN-DSS group. Data are expressed as the mean ± SEM. *Statistically significantly different (p<0.05).
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